title: Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
abstract: We describe successful management of 3 patients with streptococcal toxic shock syndrome (STSS) attributable to group G Streptococcus infection. This small series supports recognition of group G Streptococcus in the etiology of STSS. We propose intravenous immunoglobulin be used in treatment as it is for STSS caused by group A Streptococcus.
authors.forename: Melissa
authors.initials: M
authors.lastname: Baxter
authors.forename: Marina
authors.initials: M
authors.lastname: Morgan
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012703:Serotyping; D012772:Shock, Septic / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D013291:Streptococcus / Q000145:classification* / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous
keywords: IVIg; STSS; bacteria; bacterial infections; group G streptococcus; intravenous immunoglobulin; streptococcal toxic shock syndrome; streptococci; streptococcus